IGM Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	559	485	728	952	2,711	1,165	-
Market Cap Growth	-	-33.39%	-23.49%	-64.87%	132.62%	-	-
Enterprise Value	261	187	342	751	2,357	955	3
PE Ratio	-1.97	-1.97	-3.29	-5.76	-33.32	-27.01	-
PS Ratio	262.36	227.82	681.46	-	-	-	-
PB Ratio	2.75	2.39	2.54	3.89	7.10	4.85	-
P/FCF Ratio	-2.37	-2.37	-45.36	-6.89	-31.75	-24.56	-
P/OCF Ratio	-2.52	-2.52	-124.46	-7.62	-39.93	-25.83	-
EV/Sales Ratio	122.56	88.02	319.74	-	-	-	-
EV/EBITDA Ratio	-0.81	-0.81	-1.62	-4.77	-30.30	-23.42	-0.14
EV/EBIT Ratio	-0.76	-0.76	-1.55	-4.54	-28.97	-22.15	-0.13
EV/FCF Ratio	-0.92	-0.92	-21.28	-5.43	-27.60	-20.13	-0.15
Debt / Equity Ratio	0.20	0.20	0.14	0.12	0.03	0.06	-0.08
Debt / EBITDA Ratio	-0.17	-0.17	-0.20	-0.18	-0.16	-0.36	-0.22
Debt / FCF Ratio	-0.20	-0.20	-2.56	-0.21	-0.14	-0.31	-0.24
Quick Ratio	7.96	7.96	9.57	8.29	21.25	25.31	-0.06
Current Ratio	8.18	8.18	9.81	8.67	21.65	26.04	0.27
Asset Turnover	0.01	0.01	0.00	0	0	0	0
Return on Equity (ROE)	-103.20%	-103.20%	-74.00%	-54.70%	-32.50%	-49.50%	42.70%
Return on Assets (ROA)	-53.50%	-53.50%	-46.70%	-48.50%	-29.80%	-32.50%	-846.00%
Return on Capital (ROIC)	-108.09%	-108.09%	-69.41%	-60.41%	-21.13%	-17.45%	37.48%
Earnings Yield	-44.10%	-50.78%	-30.35%	-17.35%	-3.00%	-3.70%	-
FCF Yield	-36.61%	-42.17%	-2.20%	-14.52%	-3.15%	-4.07%	-
Buyback Yield / Dilution	-25.92%	-25.92%	-24.09%	-8.88%	-241.82%	-1953.40%	-0.03%
Total Shareholder Return	-25.92%	-25.92%	-24.09%	-8.88%	-241.82%	-1953.40%	-0.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).